Cite
HARVARD Citation
Patel, V. et al. (2021). Risk and cost of infection-related hospitalizations in medicare beneficiaries with comorbid rheumatoid arthritis treated with abatacept versus other targeted disease-modifying anti-rheumatic drugs. Journal of medical economics. pp. 299-307. [Online].